JP2020511159A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511159A5
JP2020511159A5 JP2019570603A JP2019570603A JP2020511159A5 JP 2020511159 A5 JP2020511159 A5 JP 2020511159A5 JP 2019570603 A JP2019570603 A JP 2019570603A JP 2019570603 A JP2019570603 A JP 2019570603A JP 2020511159 A5 JP2020511159 A5 JP 2020511159A5
Authority
JP
Japan
Prior art keywords
seq
represented
il17a
pharmaceutical composition
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019570603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511159A (ja
JP6876156B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/076278 external-priority patent/WO2018161340A1/en
Publication of JP2020511159A publication Critical patent/JP2020511159A/ja
Publication of JP2020511159A5 publication Critical patent/JP2020511159A5/ja
Application granted granted Critical
Publication of JP6876156B2 publication Critical patent/JP6876156B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019570603A 2017-03-10 2017-03-10 Ｉｌ−１７ａ及びｉｌ−１７ｆに反応するモノクローナル抗体、及びその使用 Active JP6876156B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/076278 WO2018161340A1 (en) 2017-03-10 2017-03-10 Monoclonal antibody against both il-17a and il-17f and use of the same

Publications (3)

Publication Number Publication Date
JP2020511159A JP2020511159A (ja) 2020-04-16
JP2020511159A5 true JP2020511159A5 (enExample) 2020-05-28
JP6876156B2 JP6876156B2 (ja) 2021-05-26

Family

ID=63448085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019570603A Active JP6876156B2 (ja) 2017-03-10 2017-03-10 Ｉｌ−１７ａ及びｉｌ−１７ｆに反応するモノクローナル抗体、及びその使用

Country Status (7)

Country Link
US (1) US10858427B2 (enExample)
EP (1) EP3592771A4 (enExample)
JP (1) JP6876156B2 (enExample)
KR (1) KR102321861B1 (enExample)
CN (1) CN110582512B (enExample)
AU (1) AU2017402210B2 (enExample)
WO (1) WO2018161340A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110003329B (zh) * 2019-04-12 2022-09-27 深圳普瑞金生物药业股份有限公司 多肽、il17a/f单域抗体、核苷酸序列及试剂盒
US11827709B2 (en) * 2019-12-05 2023-11-28 Seagen Inc. Anti-AVB6 antibodies and antibody-drug conjugates
CN112915201B (zh) 2019-12-06 2023-06-27 珠海市丽珠单抗生物技术有限公司 包含抗il-17抗体的液体制剂
WO2024002145A1 (zh) * 2022-06-29 2024-01-04 上海齐鲁制药研究中心有限公司 结合il-17a和il-17f的抗体分子及其应用
CN116063493B (zh) * 2022-07-22 2023-09-01 贵州省赛尔生物科技有限公司 包含抗体和间充质干细胞外泌体的药物组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
CN101326195B9 (zh) 2005-12-13 2022-11-11 伊莱利利公司 抗il-17抗体
WO2007106769A2 (en) * 2006-03-10 2007-09-20 Zymogenetics, Inc. Antibodies that bind both il-17a and il-17f and methods of using the same
CA2682889C (en) * 2007-04-27 2016-04-05 Zymogenetics, Inc. Antibodies that bind both il-17a and il-17f and methods of using the same
GB0807413D0 (en) * 2008-04-23 2008-05-28 Ucb Pharma Sa Biological products
SG190626A1 (en) * 2008-05-05 2013-06-28 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
SG174891A1 (en) 2009-04-01 2011-11-28 Genentech Inc Treatment of insulin-resistant disorders
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
PT2663577T (pt) * 2011-01-14 2017-07-19 Ucb Biopharma Sprl Anticorpo de ligação a il-17a e il-17f
SI2852615T1 (sl) 2012-05-22 2019-02-28 Bristol-Myers Squibb Company IL-17A/F IL-23 bispecifična protitelesa in njihova uporaba
TWI632159B (zh) * 2013-02-08 2018-08-11 諾華公司 抗－ｉｌ－１７ａ抗體及其於治療自體免疫及發炎病症之用途
WO2014161570A1 (en) * 2013-04-03 2014-10-09 Roche Glycart Ag Antibodies against human il17 and uses thereof
EP3027649B1 (en) 2013-08-01 2020-04-01 F.Hoffmann-La Roche Ag Tnfa-il-17 bispecific antibodies
CN106336459B (zh) * 2015-07-13 2020-12-08 三生国健药业（上海）股份有限公司 抗人白细胞介素-17a单克隆抗体、其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2020511159A5 (enExample)
RU2458071C2 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
JP2017079785A5 (enExample)
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
HRP20191608T1 (hr) Proteini s ponavljajućim dipeptidom kao terapeutsko ciljno mjesto kod neurodegenerativnih bolesti s ekspanzijom ponavljajućeg heksanukleotida
HRP20201633T1 (hr) Protutijela koja se vežu na il-23
JP2020018311A5 (enExample)
RU2011116927A (ru) Антитела против интерлейкина 17 (ил-17) человека и их применение
HRP20161141T1 (hr) Anti-il-23 protutijela
JP2017163973A5 (enExample)
JP2017184723A5 (enExample)
PE20181089A1 (es) Anticuerpos anti-cd19 humano con alta afinidad
HRP20191334T1 (hr) Anti-fcrn antitijela
JP2012501669A5 (enExample)
HRP20180516T1 (hr) Humanizirana protutijela specifična za protofibrilni oblik amiloidnog-beta peptida
RU2019118359A (ru) Антитело к cd73 человека
JP2020055849A5 (enExample)
HRP20130877T1 (hr) Antitijela koja neutraliziraju humani citomegalovirus i njihova primjena
JP2018121657A5 (enExample)
JP2014516945A5 (enExample)
RU2011135422A (ru) Человеческие анти-il-6 антитела с пролонгированным периодом выведения in vivo и их применение при лечении онкологических, аутоиммунных заболеваний и воспалительных заболеваний
JP2019522961A5 (enExample)
RU2015144026A (ru) Антитела против cd25 и их применения
JP2017099391A5 (enExample)
JP2010500005A5 (enExample)